PMC-309 monotherapy Clinical Trials

1 actively recruiting trial

Also known as: Monotherapy

Pipeline

Phase 1: 1

Top Sponsors

PharmAbcine1

Indications

Advanced or Metastatic Solid Tumors1
Cancer1

Other1 trial

Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.